Is vaccination against measles, mumps, and rubella associated with reduced rates of antibiotic treatments among children below the age of 2 years? Nationwide register-based study from Denmark, Finland, Norway, and Sweden
CONCLUSIONS: Across the Nordic countries, receipt of MMR vaccine after DTaP3 was associated with an 11% lower rate of antibiotic treatments. The negative control analysis suggests that the findings are affected by residual confounding. Findings suggest that potential non-specific effects of MMR vaccine are of limited clinical and public health importance for the milder infections treated out-of-hospital in the Nordic setting.PMID:38508926 | DOI:10.1016/j.vaccine.2024.03.026
Source: Vaccine - Category: Allergy & Immunology Authors: Lise Gehrt H élène Englund Ida Laake Heta Nieminen S ören Möller Berit Feiring Mika Lahdenkari Lill Trogstad Christine Stabell Benn Signe S ørup Source Type: research
More News: Allergy & Immunology | Children | Denmark Health | Diphtheria | Finland Health | International Medicine & Public Health | Measles | Measles Vaccine | Mumps | Mumps Vaccine | Norway Health | Rubella | Rubella Vaccine | Study | Sweden Health | Tetanus | Tetanus Diptheria Pertussis Vaccine Tdap,Dtap,Dpt | Tetanus Vaccine | Vaccines | Whooping Cough (Pertussis) Vaccine